CUE — CUE BIOPHARMA INC

Ownership history in Advisory Services Network, LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in CUE BIOPHARMA INC (CUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 200 — 0% 0.00% $144 $0.72
2023 Q4 UNCHANGED 200 — 0% 0.00% $528 $2.64
2023 Q1 UNCHANGED 200 — 0% 0.00% $714 $3.57
2022 Q4 ADDED 200 +100 +100.0% 0.00% $570 $2.85
2020 Q3 INITIATED 100 — — 0.00% $2K $15.05
% of Fund (quarterly)    CUE price (monthly, adj. close)

Other funds also holding CUE

As of 2025 Q4 — sorted by position size

Lion Point Capital, LP 3Y 7Y 3.48% Bleichroeder LP 3Y 0.37% GC Wealth Management RIA, LLC 0.05% ADVISORY RESEARCH INC 3Y 7Y 0.01% ANGELES WEALTH MANAGEMENT, LLC 3Y 0.01% Robertson Stephens Wealth Management, LLC 3Y 7Y 0.0% BOOTHBAY FUND MANAGEMENT, LLC 3Y 7Y 0.0% PREVAIL INNOVATIVE WEALTH ADVISORS, LLC 0.0% Chicago Partners Investment Group LLC 3Y 7Y 0.0% New Millennium Group LLC 3Y 0.0%
← Back to Advisory Services Network, LLC Holdings